Tenax Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,710,673 over the previous period. Total operating expenses were $8,233,941.

Profit Margin

Tenax Therapeutics, Inc. (NASDAQ:TENX): Profit margin
2014 288.72K -19.54M -6768.3%
2015 49.28K -14.08M -28571.63%
2016 0 -43.92M
2017 0 -8.83M
2018 0 -6.73M
2019 0 -8.39M
2020 0 -9.87M
2021 0 -32.73M
2022 0 -11.04M
2023 0 -7.71M

TENX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000049.28K288.72K
Cost of revenue
7.57K113.33K108.98K114.74K107.27K9.01K13.62K18.95K9.72K129.8K
Gross profit
-7.57K-113.33K-108.98K-114.74K-107.27K-9.01K-13.62K-18.95K39.55K158.92K
Operating exp.
Research and development
3.22M5.37M25.14M4.56M3.47M1.23M3.52M13.13M6.66M2.99M
Selling and marketing
0000000000
Total operating expenses
8.23M11.05M32.72M9.86M8.55M6.89M9.20M19.38M13.83M16.77M
Operating income
-8.23M-11.05M-32.72M-9.86M-8.55M-6.89M-9.20M-52.65M-14.81M-16.61M
Other income (expenses), net
523.26K4.74K253.88K16.53K160.90K79.83K366.21K-32.50M536.30K-392.53K
Income before tax
-7.71M-11.04M-32.47M-9.85M-8.39M-6.81M-8.83M-51.88M-14.08M-19.54M
Income tax expense
0-4.74K255.78K19.79K0-79.83K-366.21K-7.96M250.85K718.43K
Net income
-7.71M-11.04M-32.73M-9.87M-8.39M-6.73M-8.83M-43.92M-14.08M-19.54M
Earnings per share
Basic EPS
-31.09-600.46-2.54K-1.52K-27.1-7.35K-10.02K-624.82-200.61-834.94
Diluted EPS
-31.04-600.46-2.54K-1.52K-27.1-7.35K-10.02K-624.82-200.61-834.94
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source